What is Celestial Biolabs Ltd (CELESTIAL) share price return in the past 10 years?

Celestial Biolabs Ltd share price has declined -20.8% annually (CAGR) over the past ten years.

What is the share price of Celestial Biolabs Ltd (CELESTIAL)?

Company share prices are keep on changing according to the market conditions. The current trading price of Celestial Biolabs Ltd (CELESTIAL) on 11-Mar-2020 18:01:12 at 18:01 is 2.43.

What is the P/E ratio of Celestial Biolabs?

The latest standalone P/E ratio of Celestial Biolabs as of 11-Mar-2020 is 0.00.

What is the P/B ratio of Celestial Biolabs Ltd (CELESTIAL)?

The latest standalone P/B ratio of Celestial Biolabs Ltd (CELESTIAL) as of 11-Mar-2020 is 1.46.

What is the 52-week high and low of Celestial Biolabs Ltd (CELESTIAL)?

The 52-week high of Celestial Biolabs Ltd (CELESTIAL) is Rs. 2.43 and the 52-week low is Rs. 2.02.

Celestial Biolabs Ltd (CELESTIAL) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Celestial Biolabs Ltd (CELESTIAL)
Brand: Celestial Biolabs

Celestial Biolabs Ltd (CELESTIAL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532871 NSE: CELESTIAL Pharmaceuticals & Drugs | Small Cap | Celestial Biolabs Share Price

Celestial Biolabs Ltd (CELESTIAL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532871 NSE: CELESTIAL Pharmaceuticals & Drugs | Small Cap | Celestial Biolabs Share Price

Key Metrics

Valuation Multiples

Market Cap

₹5 Cr.

Current Price

₹2.4

52-Week Low / High

₹2 / 2

TTM EPS

₹-0.3

TTM Sales

₹0.2 Cr.

Book Value per Share

₹1.4

P/E Ratio

0.00

Industry PE

49.2

Price to Book (P/B)

1.46

Price to Sales (P/S)

23.52

EV/EBITDA

-27.71

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

-18.66%

Return on Capital Employed (ROCE)

-3.85%

Return on Assets (ROA)

-3.34%

Operating Profit Margin

-320.9%

Net Profit Margin

-339%

Gross Profit Margin

-322.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

13.33%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

26.07%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹-19 Cr.

Equity

₹22.6 Cr.

Face Value

₹10

All Time Low / High

₹1.99 / 78.25

Celestial Biolabs stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	2.8%	5.3%	3.1%	3.5%	3.8%	2.3%	-150.2%	-1.1%	-2.5%	-3.9%	-
Value Creation Index ⓘ	-0.8	-0.6	-0.8	-0.8	-0.7	-0.8	-11.7	-1.1	-1.2	-1.3	-
Growth Parameters ⓘ
Sales ⓘ	23.5	27.5	32.9	38.7	42.8	49	5.2	0	0.2	0.2	0
Sales YoY Gr.	-	16.8%	19.7%	17.7%	10.7%	14.4%	-89.3%	-100%	NA	13.3%	-
Adj EPS ⓘ	0.5	0.7	1	1.5	1.5	-0	-36.9	-0.1	-0.2	-0.3	-0.3
YoY Gr.	-	42.9%	45.7%	45.1%	3.4%	-100.7%	NA	NA	NA	NA	-
BVPS (₹) ⓘ	49.3	43.6	44	43.8	45.3	45.3	1.7	1.7	1.5	1.2	1.4
Adj Net Profit ⓘ	0.8	1.3	2.1	3.3	3.5	-0	-83.3	-0.2	-0.4	-0.6	-1
Cash Flow from Ops. ⓘ	3.3	5.8	8	13.4	3.3	16.7	-3.1	-0	-0.3	-0.4	-
Debt/CF from Ops. ⓘ	5.6	1.9	1	0.6	2.9	0.8	-3.7	-329.9	-41.9	-34.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-42.2%	-66.9%	-68.1%	13.3%
Adj EPS ⓘ	-192.8%	-169.6%	NA	NA
BVPSⓘ	-33.7%	-51.4%	-10.9%	-16.9%
Share Price	-20.8%	3.8%	6.4%	20.3%

Key Financial Parameters ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	1	1.5	2.3	3.4	3.4	-0	-156.9	-4.5	-11.5	-18.7	-20.6
Op. Profit Mgn % ⓘ	33	45.3	26	18.1	27.6	24	-1428.1	0	-229.2	-320.9	-273.2
Net Profit Mgn % ⓘ	3.6	4.7	6.3	8.6	8.1	-0.1	-1593.9	0	-277.6	-339	-321
Debt to Equity ⓘ	0.2	0.1	0.1	0.1	0.1	0.1	2.9	3	3.4	4.3	-
Working Cap Days ⓘ	587	583	517	308	208	201	935	0	10,478	9,063	5,008
Cash Conv. Cycle ⓘ	207	240	234	171	169	170	868	0	9,096	8,040	-1,603

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	23.50	27.45	32.86	38.66	42.81	48.97	5.23	0	0.15	0.17
Operating Expenses ⓘ +	15.75	15.02	24.30	31.67	30.99	37.24	101.33	0.16	0.49	0.71
Manufacturing Costs	1.40	1.88	4.42	4.87	1	0.62	0.05	0.02	0.04	0.13
Material Costs	8.87	5.43	16.04	24.38	28.64	28.49	3.27	0	0.06	0.08
Employee Cost	0.76	0.89	0.92	1.08	0.63	1.48	0.27	0.03	0.12	0.20
Other Costs ⓘ	4.73	6.82	2.92	1.34	0.71	6.65	97.74	0.11	0.26	0.30
Operating Profit ⓘ	7.75	12.43	8.56	7	11.83	11.74	-96.10	-0.16	-0.34	-0.54
Operating Profit Margin (%)	33.0%	45.3%	26.0%	18.1%	27.6%	24.0%	-1,838.1%	-	-229.0%	-320.0%
Other Income ⓘ +	0	0	0.29	0	0	0.36	0.04	0.03	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2.22	4.15	1.29	0.02	0.03	1.25	1.43	0	0.04	0
Depreciation ⓘ	4.98	7.06	5.71	3.30	7.70	9.44	2.26	0.04	0.03	0.03
Profit Before Tax ⓘ	0.55	1.23	1.85	3.67	4.11	1.40	-99.75	-0.17	-0.41	-0.57
Tax ⓘ	-0.29	-0.07	-0.23	0.34	0.65	1.43	-1.41	0	0	0
Profit After Tax	0.84	1.30	2.08	3.33	3.46	-0.03	-98.34	-0.17	-0.41	-0.57
PAT Margin (%)	3.6%	4.7%	6.3%	8.6%	8.1%	-0.1%	-1,880.9%	-	-277.0%	-339.0%
Adjusted EPS (₹)	0.5	0.7	1.0	1.5	1.5	-0.0	-43.5	-0.1	-0.2	-0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Celestial Biolabs - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund +	85.60	80.81	90.06	98.84	102.30	102.27	3.93	3.76	3.35	2.78
Share Capital ⓘ	17.35	18.56	20.49	22.59	22.59	22.59	22.59	22.59	22.59	22.59
Reserves ⓘ	68.25	62.25	69.57	76.26	79.71	79.69	-18.66	-18.83	-19.24	-19.81
Debt +	18.44	11.17	8.25	8.25	4.82	7.82	8.18	11.28	11.54	11.91
Long Term Debt	18.44	11.17	8.25	8.25	4.82	7.82	8.18	8.23	8.49	8.86
Short Term Debt	0	0	0	0	0	0	0	3.05	3.05	3.05
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.37	0.65	0.69	0.42	0.43	0.56	0.34	0.38	0.26	0.27
Others Liabilities ⓘ	-0	6.48	6	1.03	6.40	8.68	4.80	1.75	2.03	2.08
Total Liabilities ⓘ	104.42	99.11	104.99	108.55	113.95	119.33	17.25	17.17	17.18	17.03
Fixed Assets
Net Fixed Assets ⓘ +	36.82	27.78	26.45	60.85	53.10	51.51	0.17	0.13	0.10	0.08
Gross Block	63.36	61.39	65.75	103.46	102.55	110.41	11.84	11.84	11.85	11.85
Accumulated Depreciation	26.54	33.60	39.31	42.61	49.45	58.89	11.67	11.71	11.74	11.77
CWIP ⓘ	24.68	25.19	29.56	29.56	29.56	45.24	12.82	12.82	12.82	12.82
Investments ⓘ	0	0	0.30	0.30	0	0	0	0	0	0
Inventories	7.27	12.71	9.66	7.72	3.96	6.14	0.05	0.05	0.05	0.03
Trade Receivables	9.04	9	11.95	8.25	20.77	15.64	3.83	3.78	3.83	3.71
Cash Equivalents	0.55	0.85	0.92	0.41	0.01	0.05	0.01	0.02	0	0.02
Others Assets ⓘ	26.06	23.59	26.15	1.46	6.56	0.76	0.37	0.38	0.38	0.38
Total Assets ⓘ	104.42	99.11	104.99	108.55	113.95	119.33	17.25	17.17	17.18	17.03

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ +	3.27	5.79	8.02	13.40	3.34	16.65	-3.06	-0.03	-0.28	-0.35
PBT ⓘ	0.55	1.23	1.85	3.67	4.11	1.40	-99.75	-0.17	-0.41	-0.57
Adjustment ⓘ	7.49	11.27	7.12	2.98	7.07	10.69	81.11	0.04	0.03	0.03
Changes in Working Capital ⓘ	-4.77	-6.71	-0.95	6.75	-7.84	4.55	15.58	0.1	0.1	0.2
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-8.19	-3.60	-11.61	-13.89	-4.88	-18.66	4.09	0	-0	-0.01
Capex	-2.50	-3.10	-0.89	0	0	-0	4.09	0	-0	-0.01
Net Investments	0	0	-0.30	0	0	0	0	0	0	0
Others ⓘ	-5.69	-0.50	-10.42	-13.89	-4.88	-18.65	0	0	0	-0
Cash Flow From Financing Activity ⓘ +	5.30	-1.88	3.66	-0.02	1.14	2.05	-1.07	0.05	0.26	0.37
Net Proceeds from Shares ⓘ	5.50	1.21	1.93	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	1.17	3	0.36	0.05	0.26	0.37
Interest Paid ⓘ	-2.22	-4.15	-1.19	-0.02	-0.03	-1.25	-1.43	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	2.01	1.06	2.92	0	-0	0.30	-0	0	0	0
Net Cash Flow ⓘ	0.38	0.30	0.07	-0.51	-0.40	0.04	-0.04	0.01	-0.02	0.02

Financial Ratio

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	1.02	1.56	2.43	3.53	3.44	-0.03	-185.19	-4.46	-11.52	-18.66
ROCE (%)	2.79	5.33	3.12	3.5	3.78	2.33	-150.19	-1.13	-2.46	-3.85
Asset Turnover Ratio	0.24	0.27	0.32	0.36	0.38	0.42	0.08	0	0.01	0.01
PAT to CFO Conversion(x)	3.89	4.45	3.86	4.02	0.97	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	115.20	120	116.40	95.40	123.70	135.70	679.40	0	9,419.50	8,157.20
Inventory Days	97.60	132.80	124.30	82	49.80	37.60	216	0	124.80	89.40
Payable Days	13.10	34.30	15.20	8.30	5.50	6.40	50	0	1,878.20	1,201.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Celestial Biolabs Ltd FAQs

The current trading price of Celestial Biolabs on 11-Mar-2020 18:01 is ₹2.43.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Mar-2020 the market cap of Celestial Biolabs stood at ₹4.56 Cr

The latest P/E ratio of Celestial Biolabs as of 10-Mar-2020 is 0.00.

The latest P/B ratio of Celestial Biolabs as of 10-Mar-2020 is 1.46.

The 52-week high of Celestial Biolabs is ₹2.43 and the 52-week low is ₹2.02.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Celestial Biolabs is ₹0.19 ( Cr.) .

Data is not available for this company.

The key valuation ratios of Celestial Biolabs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

No data found

About Celestial Biolabs Ltd

Celestial Labs Limited was incorporated as a Private Limited Company on November 19, 1997 as Celestial Technologies Private Limited. The company was later converted into a Public Limited Company under the name Celestial Technologies Limited'on December 6, 1999 and has been subsequently renamed as Celestial Labs Limited effective from February 13, 2004.

Celestial Labs ( CLL ) has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research. CLL also involved in the R&D, commercial production and marketing of enzymes, nutraceuticals.Celestial Labs is setting up a biotechnology facility in Genome Valley at Hyderabad, India to manufacture its own drug molecules, industrial enzymes and to contract research activities.

Celestial Labs Ltd (CLL) is an ISO 9001-2001 certified company with a decade of experience in Insilico Drug Discovery and Development, and contract research services.Celestial Labs is recognized by DSIR (Government of India) for its R&D endeavors in the Insilco Drug Discovery software development. Celestial has been providing customized solutions and services in Bio-IT as well as research services over a decade.

The business plan of Celestial Labs is essentially based on the production and supply of the biotechnological products which have very significant industrial implications, especially in both Pharma and Bio-pharmaceutical sectors. The plan is envisaged after a thorough ground-work in terms of building up of a technology base through stake holders and collaborators, further supported by market analysis and import-export imperatives. Celestial's ambitious goals earmarked with well-worked road map, strategic implementation and management tools are well supported by its competent and experienced personnel to effectively carry out the scientific, engineering, finance and management functions of its project activities.

Products and services offered by the company:Products:

Informatics
Enzymes
Neutraceuticals
Peptides

Services:

Drug Discovery Services
Bio Technology
Bio IT Services

Achievements/ recognition :

ISO 9001 â€“ 2001 certified company
Recognized by DSIR (Government of India) for its R&D endeavors in the Insilco Drug Discovery software development

Celestial Biolabs Ltd (CELESTIAL)

Celestial Biolabs Ltd (CELESTIAL)

Celestial Biolabs stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Celestial Biolabs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Celestial Biolabs Ltd FAQs

About Celestial Biolabs Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Celestial Biolabs Ltd (CELESTIAL)

Celestial Biolabs Ltd (CELESTIAL)

Celestial Biolabs stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Celestial Biolabs - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Celestial Biolabs Ltd FAQs

What is the share price of Celestial Biolabs?

What is the market cap of Celestial Biolabs?

What is the P/E ratio of Celestial Biolabs?

What is the P/B ratio of Celestial Biolabs?

What is the 52-week high and low of Celestial Biolabs?

What is the TTM revenue of Celestial Biolabs?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Celestial Biolabs Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.